Artiva Biotherapeutics, Inc. (ARTV) Reports Q2 Loss of $0.87
Tweet
Share
E-mailGet Alerts ARTV Hot Sheet
Join SI Premium – FREE
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) reported Q2 EPS of ($0.87), versus $0.00 reported last year.
For earnings history and earnings-related data on Artiva Biotherapeutics, Inc. (ARTV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Jane Street Took $15 Billion Hit In July Tied To Situational Awareness - Reuters
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
